David Siegel MD, MPH
David Siegel, MD, MPH, is a pediatric hematologist/oncologist and a Lieutenant Commander in the Commissioned Corps of the U.S. Public Health Service. He joined the Centers for Disease Control and Prevention as an Epidemic Intelligence Service Officer in the Division of Cancer Prevention and Control (DCPC) from 2016 to 2018 and remained in DCPC as a medical officer. Dr. Siegel focuses his work and research on pediatric, young adult, prostate, and tobacco-associated cancers and on using cancer registry data to improve disparities in clinical trial enrollment and outcomes.
Dr. Siegel attended Washington University in St. Louis for his undergraduate studies and the George Washington University School of Medicine for medical school. He completed a pediatric residency and a pediatric hematology/oncology fellowship at Emory University and Children’s Healthcare of Atlanta.
Some of the articles Dr. Siegel has first-authored include—
- 2020 Proportion of never smokers among men and women with lung cancer in 7 US states.external icon
- 2020 Pediatric cancer mortality and survival in the United States, 2001–2016.external icon
- 2020 Prostate cancer incidence and survival, by stage and race/ethnicity—United States, 2001–2017.
- 2019 Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United States.external icon
- 2019 Update: Interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung injury—United States, October 2019.
- 2018 Capture of tobacco use among population-based registries: Findings from 10 National Program of Cancer Registries states.external icon
- 2018 Geographic variation in pediatric cancer incidence—United States, 2003–2014.
- 2017 Rates and trends of pediatric acute lymphoblastic leukemia—United States, 2001–2014.
- 2014 Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009.external icon